Jacobio Pharmaceuticals Group Co., Ltd. is an investment holding company, which engages in the research and development of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 211 full-time employees. The company went IPO on 2020-12-21. The firm is primarily responsible for the independent discovery and development of innovative tumor therapies. The firm's main drug development projects include JAB-21822 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The firm mainly operates its businesses in China market.
01167.HK stock price ended at $6.09 on 星期四, after dropping 2.40%
On the latest trading day Feb 12, 2026, the stock price of 01167.HK fell by 2.40%, dropping from $6.22 to $6.09. During the session, the stock saw a volatility of 4.14%, with prices oscillating between a daily low of $6.04 and a high of $6.29. On the latest trading day, the trading volume for 01167.HK decreased by 1.2M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.7M shares were traded, with a market value of approximately $4.7B.